These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 11759973

  • 21. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT, Yassin MA, De Sanctis V.
    Acta Biomed; 2018 Feb 16; 89(2-S):27-32. PubMed ID: 29451226
    [Abstract] [Full Text] [Related]

  • 22. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A, Arini MI, Zarina AL, Zulkifli SZ, Jamal R.
    Southeast Asian J Trop Med Public Health; 2008 Sep 16; 39(5):900-5. PubMed ID: 19058587
    [Abstract] [Full Text] [Related]

  • 23. [Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major].
    Rodríguez Galindo C, Ortega Aramburu JJ, Alonso JL, Albisu M, Casaldáliga J, Díaz de Heredia C, Olivé T, Bastida P.
    Med Clin (Barc); 1994 May 21; 102(19):721-4. PubMed ID: 8041200
    [Abstract] [Full Text] [Related]

  • 24. Zinc status in patients with major beta-thalassemia.
    Mehdizadeh M, Zamani G, Tabatabaee S.
    Pediatr Hematol Oncol; 2008 May 21; 25(1):49-54. PubMed ID: 18231954
    [Abstract] [Full Text] [Related]

  • 25. [Thalassaemia minor: national survey of uraemic patients under substitutive treatment].
    Di Iorio BR, Aucella F, Stallone C, Bellizzi V, Thalassaemia Minor in Hemodialysis Study Group.
    G Ital Nefrol; 2002 May 21; 19(3):286-93. PubMed ID: 12195396
    [Abstract] [Full Text] [Related]

  • 26. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
    Basak AN.
    Hemoglobin; 2007 May 21; 31(2):233-41. PubMed ID: 17486506
    [Abstract] [Full Text] [Related]

  • 27. Long term audiological evaluation of beta-thalassemic patients.
    Kontzoglou G, Koussi A, Economou M, Tsatra I, Perifanis V, Noussios G, Athanassiou-Metaxa M.
    Acta Otorhinolaryngol Belg; 2004 May 21; 58(2):113-7. PubMed ID: 15515654
    [Abstract] [Full Text] [Related]

  • 28. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening.
    Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P.
    Ann Hematol; 2004 Jul 21; 83(7):430-3. PubMed ID: 14722738
    [Abstract] [Full Text] [Related]

  • 29. Spinal cord compression and extramedullary hematopoiesis in young Egyptian beta-thalassemia patients.
    Tantawy AA, Adly AA, Mahdy SA, Kamel GZ.
    Hemoglobin; 2009 Jul 21; 33(6):448-62. PubMed ID: 19958190
    [Abstract] [Full Text] [Related]

  • 30. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S, Tang H, Jensen JH, Altmann K, Prakash A, Printz BF, Hordof AJ, Tosti CL, Azabagic A, Swaminathan S, Brown TR, Olivieri NF, Brittenham GM.
    Ann N Y Acad Sci; 2005 Jul 21; 1054():358-72. PubMed ID: 16339684
    [Abstract] [Full Text] [Related]

  • 31. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations.
    Verma IC, Kleanthous M, Saxena R, Fucharoen S, Winichagoon P, Raizuddin S, Khan SN, Akbari MT, Izadyar M, Kotea N, Old JM, Ioannou PA, Khan B.
    Hemoglobin; 2007 Jul 21; 31(4):439-52. PubMed ID: 17994378
    [Abstract] [Full Text] [Related]

  • 32. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ, Göbel U, Christaras A, Janssen G.
    Klin Padiatr; 2005 Jul 21; 217(3):120-5. PubMed ID: 15858702
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR, De Sanctis V, Gilli G.
    Pediatr Endocrinol Rev; 2008 Oct 21; 6 Suppl 1():158-69. PubMed ID: 19337172
    [Abstract] [Full Text] [Related]

  • 39. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E.
    Pediatr Blood Cancer; 2007 Sep 21; 49(3):329-32. PubMed ID: 17554789
    [Abstract] [Full Text] [Related]

  • 40. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z.
    Fundam Clin Pharmacol; 2009 Jun 21; 23(3):359-65. PubMed ID: 19453758
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.